GW
BMY icon

GW & Wade’s Bristol-Myers Squibb BMY Stock Holding History

GW & Wade’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.61M Sell
31,409
-1,357
-4% -$71.2K 0.05% 187
2023
Q3 		$1.9M Buy
32,766
+1,555
+5% +$95.3K 0.07% 166
2023
Q2 		$2M Buy
31,211
+879
+3% +$58.9K 0.07% 163
2023
Q1 		$2.1M Sell
30,332
-831
-3% -$58.6K 0.08% 147
2022
Q4 		$2.24M Buy
31,163
+36
+0.1% +$2.71K 0.09% 137
2022
Q3 		$2.21M Buy
31,127
+702
+2% +$50.9K 0.11% 130
2022
Q2 		$2.34M Buy
30,425
+1,082
+4% +$82.4K 0.11% 132
2022
Q1 		$2.14M Buy
29,343
+1,302
+5% +$87.4K 0.09% 127
2021
Q4 		$1.75M Buy
28,041
+939
+3% +$55.1K 0.08% 148
2021
Q3 		$1.6M Buy
27,102
+167
+0.6% +$11K 0.08% 150
2021
Q2 		$1.8M Sell
26,935
-352
-1% -$23K 0.09% 140
2021
Q1 		$1.72M Buy
27,287
+3,454
+14% +$215K 0.09% 128
2020
Q4 		$1.48M Buy
23,833
+5,728
+32% +$352K 0.09% 114
2020
Q3 		$1.09M Sell
18,105
-271
-1% -$16.3K 0.08% 111
2020
Q2 		$1.08M Buy
18,376
+22
+0.1% +$1.32K 0.09% 110
2020
Q1 		$1.02M Sell
18,354
-369
-2% -$22.6K 0.1% 105
2019
Q4 		$1.2M Sell
18,723
-635
-3% -$36.4K 0.09% 114
2019
Q3 		$982K Sell
19,358
-209
-1% -$9.82K 0.08% 116
2019
Q2 		$887K Buy
19,567
+45
+0.2% +$2.1K 0.08% 116
2019
Q1 		$931K Sell
19,522
-1,757
-8% -$87.5K 0.09% 115
2018
Q4 		$1.11M Buy
21,279
+930
+5% +$50K 0.12% 107
2018
Q3 		$1.26M Buy
20,349
+35
+0.2% +$2.08K 0.13% 104
2018
Q2 		$1.12M Sell
20,314
-1,175
-5% -$63.5K 0.13% 107
2018
Q1 		$1.36M Sell
21,489
-99
-0.5% -$6.37K 0.16% 98
2017
Q4 		$1.32M Buy
21,588
+34
+0.2% +$2.13K 0.15% 95
2017
Q3 		$1.37M Sell
21,554
-2,346
-10% -$137K 0.17% 94
2017
Q2 		$1.33M Sell
23,900
-102
-0.4% -$5.55K 0.17% 92
2017
Q1 		$1.3M Buy
24,002
+505
+2% +$27.7K 0.17% 88
2016
Q4 		$1.37M Sell
23,497
-112
-0.5% -$6.12K 0.23% 81
2016
Q3 		$1.27M Buy
23,609
+792
+3% +$50.9K 0.23% 80
2016
Q2 		$1.68M Buy
22,817
+736
+3% +$52K 0.29% 79
2016
Q1 		$1.41M Buy
22,081
+1,616
+8% +$102K 0.28% 68
2015
Q4 		$1.41M Buy
20,465
+1,013
+5% +$66.9K 0.3% 65
2015
Q3 		$1.15M Sell
19,452
-746
-4% -$47.3K 0.26% 78
2015
Q2 		$1.34M Buy
20,198
+678
+3% +$44.7K 0.27% 77
2015
Q1 		$1.26M Sell
19,520
-24,542
-56% -$1.54M 0.24% 84
2014
Q4 		$2.6M Sell
44,062
-380
-0.9% -$21.4K 0.68% 46
2014
Q3 		$2.27M Sell
44,442
-3,816
-8% -$191K 0.66% 46
2014
Q2 		$2.34M Sell
48,258
-153
-0.3% -$7.54K 0.69% 45
2014
Q1 		$2.52M Buy
48,411
+2,256
+5% +$120K 0.81% 45
2013
Q4 		$2.45M Sell
46,155
-50,033
-52% -$2.55M 0.8% 45
2013
Q3 		$4.45M Buy
96,188
+487
+0.5% +$21.4K 1.54% 17
2013
Q2 		$4.28M Buy
+95,701
New +$4.15M 1.54% 18

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GW & Wade's BMY Position: Q4 2023 in Review

GW & Wade reduced its Bristol-Myers Squibb (BMY) stake by 4.1% in Q4 2023, selling an estimated $71.2K and leaving 31,409 shares worth $1.61M. The position accounts for 0.05% of the portfolio, ranked #187.

GW & Wade first reported a position in BMY in Q2 2013 and has held it in 43 quarters since. The position peaked at $4.45M in Q3 2013. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • GW & Wade held 31,409 shares of Bristol-Myers Squibb worth $1.61M as of Q4 2023.
  • GW & Wade sold 1,357 Bristol-Myers Squibb shares in Q4 2023, an estimated $71.2K.
  • Bristol-Myers Squibb made up 0.05% of GW & Wade's portfolio in Q4 2023, its #187 holding.
  • GW & Wade first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 43 quarters since.
  • GW & Wade's Bristol-Myers Squibb position peaked at $4.45M in Q3 2013.
  • 2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.